How to predict para-aortic node involvement in advanced cervical cancer? Development of a predictive score. A
H T Nguyen-Xuan1, L Benoit2, Y Dabi3
1Department of Gynaecology and Obstetrics, Intercommunal Hospital Centre of Poissy-Saint-Germain-en-Laye, 78300, Poissy, France; Department of Gynaecology and Obstetrics, Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges Pompidou, France.
Summary
A new score helps predict para-aortic lymph node involvement in advanced cervical cancer. This tool can identify low-risk patients who may avoid extensive staging and irradiation.
Area of Science:
- Oncology
- Radiotherapy
- Medical Imaging
Background:
- Node involvement is a key prognostic factor in cervical cancer.
- Para-aortic lymph node (PALN) assessment is critical for treatment planning in advanced cervical cancer, particularly for defining irradiation fields.
Purpose of the Study:
- To develop and validate a predictive score for para-aortic lymph node involvement in patients with advanced cervical cancer.
Main Methods:
- A multicenter, retrospective study involving 498 patients with advanced squamous cell cervical cancer across 9 French centers (2000-2015).
- PALN status was assessed via imaging and/or surgery.
- Univariate and multivariate logistic regression analyses were used to identify factors associated with PALN involvement, leading to the development of a predictive score.
Main Results:
- Out of 498 patients, 91 (18.3%) had positive PALN.
- Key predictors identified for the score included tumor size on pelvic MRI, initial squamous cell carcinoma (SCC) status, and suspected pelvic node involvement on PET-CT.
- The developed score effectively divided patients into three risk groups, with an Area Under the ROC Curve of 0.81.
- PALN involvement was 9% in the low-risk group and 43% in the high-risk group.
Conclusions:
- A simple, validated score effectively predicts para-aortic lymph node involvement in advanced cervical cancer.
- This score allows for the stratification of patients into low, intermediate, and high-risk groups.
- Patients identified as low-risk may potentially avoid para-aortic staging and extensive radiation fields, optimizing treatment strategies.


